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Background: Left ventricular (LV) chamber remodeling and myocardial mid wall fibrosis (MWF) have each been linked to adverse clinical 
outcomes. This study tested relationships between MWF and LV wall stress (WS).
Methods: LV volumes, myocardial mass, and ejection fraction (EF) were quantified on cine CMR. MWF (mid myocardial septal fibrosis) was 
identified via delayed enhancement CMR. Blood pressure (BP) was measured non invasively, with systolic WS calculated via an established formula 
(systolic BP / [(LV volume + myocardial volume)2/3/LV volume -1]).
results: 281 cardiomyopathy patients with LV dysfunction (EF≤40% [mean 27±8%]) had CMR and BP within 1 day (4.3±5.9 hrs). MWF was 
present in 32 (11%) and was associated with higher WS (36±9 vs 33±9 kPa; p=0.04). Among WS components, LV end diastolic volume (293±98 vs 
223±73 ml) and mass (221±55 vs 188±56 gm) were higher among MWF+ patients (both p≤0.001) whereas BP did not differ (121±21 vs 118±20 
mmHg; p=0.4). MWF prevalence tended to increase vs. population tertiles of WS (p=0.06), corresponding to increased prevalence when stratified 
by LV volume and mass (both p<0.01; Figure). In multivariate analysis, MWF was associated with LV end diastolic volume (OR=1.14 per 10 ml [CI 
1.01-1.28, p=0.04) and non-ischemic cardiomyopathic etiology (OR=15.0 [CI 5.5-41.5], p=<0.001), but not myocardial mass (OR=0.94 per 10 gm 
[0.78-1.13], p=0.5).
conclusion: Among cardiomyopathy patients, MWF associated increased WS is primarily attributable to LV chamber dilation. 
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